Recall Sours Abbott’s Infant Formula Results; COVID-19 Test Sales Expected To Cool

 
• By Malcolm Spicer
  
Abbott's nutrition sales, adult as well as pediatric products, during Q1 dropped reported 7% to $1.89bn as it recalled Similac and other infant formula brands. • Source: Alamy

More from Earnings

More from Business